Author:
Kim Chang-Suk,Kim Eun-Kyong,Lee Kyeong-Soo,Lee Hee-Kyung,Choi Youn-Hee,Hwang Tae-Yoon,Moon Jun Sung
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynaecology,Reproductive Medicine,General Medicine
Reference27 articles.
1. World Health Organization. WHO technical report series 843. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Geneva: World Health Organization; 1994.
2. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res. 2007;22:465–75.
3. Bone HG, Greenspan SL, McKeever C, Bell N, Davidson M, Downs RW. Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group. J Clin Endocrinol Metab. 2000;85:720–6.
4. Imai Y, Youn MY, Kondoh S, Nakamura T, Kouzmenko A, Matsumoto T, et al. Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts. Ann N Y Acad Sci. 2009;1173 Suppl 1:E31–39.
5. Zhao R. Immune regulation of osteoclast function in postmenopausalosteoporosis: a critical interdisciplinary perspective. Int J Med Sci. 2012;9:825–32.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献